Our mission is to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments.

Our Development Pipeline

We believe that the legalization of the cannabis industry will create an explosion in demand for cannabinoid-based pharmaceutical therapies, technology, facilities, and financial services. While early, we expect to have a first mover advantage by developing novel therapies, applying for patents, and acquiring technologies from related industries to crossover to cannabis once federal laws permit.

Our Team